Christophe Labrière

477 total citations
14 papers, 346 citations indexed

About

Christophe Labrière is a scholar working on Molecular Biology, Pharmacology and Ocean Engineering. According to data from OpenAlex, Christophe Labrière has authored 14 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Ocean Engineering. Recurrent topics in Christophe Labrière's work include Marine Ecology and Invasive Species (3 papers), Microtubule and mitosis dynamics (3 papers) and Marine Sponges and Natural Products (3 papers). Christophe Labrière is often cited by papers focused on Marine Ecology and Invasive Species (3 papers), Microtubule and mitosis dynamics (3 papers) and Marine Sponges and Natural Products (3 papers). Christophe Labrière collaborates with scholars based in France, Norway and Sweden. Christophe Labrière's co-authors include Johan Svenson, Catherine Guillou, Frank Kozielski, Jørn H. Hansen, Robert N. Young, Gunnar Cervin, Henrik Pavia, Dimitrios A. Skoufias, Artem Cherkasov and Oliver Rath and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Christophe Labrière

14 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christophe Labrière France 12 151 89 61 49 46 14 346
Dominique Roecklin France 9 311 2.1× 37 0.4× 93 1.5× 117 2.4× 20 0.4× 11 679
Jun-Ho Jang United States 11 264 1.7× 33 0.4× 37 0.6× 17 0.3× 16 0.3× 14 472
Claudia Malaguti Italy 10 262 1.7× 50 0.6× 23 0.4× 30 0.6× 60 1.3× 16 412
Daniela Pereira Portugal 12 151 1.0× 118 1.3× 82 1.3× 2 0.0× 12 0.3× 22 384
Sarah J. H. Hickford New Zealand 5 133 0.9× 143 1.6× 40 0.7× 21 0.4× 42 0.9× 6 512
Mónica Suárez Korsnes Norway 12 203 1.3× 23 0.3× 15 0.2× 14 0.3× 29 0.6× 16 377
Hisao Nojiri Japan 14 350 2.3× 67 0.8× 6 0.1× 12 0.2× 89 1.9× 18 459
Yanxin Zheng China 11 123 0.8× 19 0.2× 14 0.2× 51 1.0× 7 0.2× 42 360
Roger P. Walker United States 14 179 1.2× 305 3.4× 77 1.3× 12 0.2× 7 0.2× 19 839
Randall E. Bolger United States 7 357 2.4× 66 0.7× 4 0.1× 212 4.3× 28 0.6× 9 677

Countries citing papers authored by Christophe Labrière

Since Specialization
Citations

This map shows the geographic impact of Christophe Labrière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Labrière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Labrière more than expected).

Fields of papers citing papers by Christophe Labrière

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Labrière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Labrière. The network helps show where Christophe Labrière may publish in the future.

Co-authorship network of co-authors of Christophe Labrière

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Labrière. A scholar is included among the top collaborators of Christophe Labrière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Labrière. Christophe Labrière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Labrière, Christophe, et al.. (2022). Development of potent cholinesterase inhibitors based on a marine pharmacophore. Organic & Biomolecular Chemistry. 20(28). 5589–5601. 3 indexed citations
2.
Labrière, Christophe, Gunnar Cervin, Henrik Pavia, Jørn H. Hansen, & Johan Svenson. (2021). Structure–Activity Relationship Probing of the Natural Marine Antifoulant Barettin. Marine Biotechnology. 23(6). 904–916. 15 indexed citations
3.
Labrière, Christophe, Gunnar Cervin, Karine Réhel, et al.. (2020). Phidianidine A and Synthetic Analogues as Naturally Inspired Marine Antifoulants. Journal of Natural Products. 83(11). 3413–3423. 36 indexed citations
4.
Moodie, Lindon W. K., Gunnar Cervin, Rozenn Trépos, et al.. (2018). Design and Biological Evaluation of Antifouling Dihydrostilbene Oxime Hybrids. Marine Biotechnology. 20(2). 257–267. 22 indexed citations
5.
Labrière, Christophe, et al.. (2018). Heterocyclic cellular lipid peroxidation inhibitors inspired by the marine antioxidant barettin. Bioorganic Chemistry. 84. 106–114. 12 indexed citations
6.
Labrière, Christophe, Nahid Kondori, Kerstin Sandholm, et al.. (2018). Development and evaluation of cationic amphiphilic antimicrobial 2,5‐diketopiperazines. Journal of Peptide Science. 24(7). e3090–e3090. 21 indexed citations
7.
Labrière, Christophe, Huansheng Gong, B. Brett Finlay, Neil E. Reiner, & Robert N. Young. (2016). Further investigation of inhibitors of MRSA pyruvate kinase: Towards the conception of novel antimicrobial agents. European Journal of Medicinal Chemistry. 125. 1–13. 20 indexed citations
8.
Labrière, Christophe, et al.. (2016). Further investigation of Paprotrain: Towards the conception of selective and multi-targeted CNS kinase inhibitors. European Journal of Medicinal Chemistry. 124. 920–934. 13 indexed citations
9.
Labrière, Christophe, Sandeep K. Talapatra, Sylviane Thoret, et al.. (2015). New MKLP-2 inhibitors in the paprotrain series: Design, synthesis and biological evaluations. Bioorganic & Medicinal Chemistry. 24(4). 721–734. 22 indexed citations
10.
Leblanc, Eric, Peter Axerio-Cilies, Christophe Labrière, et al.. (2013). Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole Derivatives. Journal of Medicinal Chemistry. 56(3). 1136–1148. 78 indexed citations
11.
Kumar, Nag S., Artem Cherkasov, B. Brett Finlay, et al.. (2012). Optimization and structure–activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents. Bioorganic & Medicinal Chemistry. 20(24). 7069–7082. 26 indexed citations
12.
Tcherniuk, Sergey, Dimitrios A. Skoufias, Christophe Labrière, et al.. (2010). Relocation of Aurora B and Survivin from Centromeres to the Central Spindle Impaired by a Kinesin‐Specific MKLP‐2 Inhibitor. Angewandte Chemie International Edition. 49(44). 8228–8231. 50 indexed citations
13.
Tcherniuk, Sergey, Dimitrios A. Skoufias, Christophe Labrière, et al.. (2010). Relocation of Aurora B and Survivin from Centromeres to the Central Spindle Impaired by a Kinesin‐Specific MKLP‐2 Inhibitor. Angewandte Chemie. 122(44). 8404–8407. 1 indexed citations
14.
Gaquerel, Emmanuel, Cécile Hervé, Christophe Labrière, et al.. (2007). Evidence for oxylipin synthesis and induction of a new polyunsaturated fatty acid hydroxylase activity in Chondrus crispus in response to methyljasmonate. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1771(5). 565–575. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026